Cabrera Gustavo, Perretta Fernando
Centro Cardiovascular Bolívar, Departamento de Ecocardiografía, Buenos Aires, Argentina.
Co-Director Médico Fresenius Pilar, Buenos Aires, Argentina.
Mol Genet Metab Rep. 2018 Sep 8;17:16-17. doi: 10.1016/j.ymgmr.2018.07.001. eCollection 2018 Dec.
Fabry disease is a genetic disorder characterized by the accumulation of globotriaosylceramide in cell lysosomes resulting from an X-linked deficiency of α-galactosidase A activity. It presents with multiorgan manifestations, including progressive renal disease, cardiomyopathy and premature demise. Recently, its prevalence has been reported to be higher in hemodialysis (HD) patients than in the general population. We report two cases of homozygous patients with an intronic alpha-galactosidase gene mutation and a classic phenotype of the disease. One of the patients had a kidney transplant and the donor was his brother, before Fabry disease were diagnose.
法布里病是一种遗传性疾病,其特征是由于X连锁的α-半乳糖苷酶A活性缺乏,导致细胞溶酶体中球三糖神经酰胺蓄积。它表现为多器官症状,包括进行性肾病、心肌病和过早死亡。最近有报道称,血液透析(HD)患者中法布里病的患病率高于普通人群。我们报告了两例纯合子患者,他们存在内含子α-半乳糖苷基因突变,且具有该疾病的典型表型。其中一名患者在法布里病被诊断之前接受了肾脏移植,供体是他的兄弟。